X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/mundipharma-international-corporation-limited-mundipharma-medical-company-and-acrotech-biopharma-inc-enter-agreement-to-transfer-license-of-folotyn-pralatrexate-in-china-to-casi-pharmaceuticals-301889557.html
https://www.fiercepharma.com/pharma/most-expensive-meds-u-s-topped-by-novartis-and-spark-gene-therapies
https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/
https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1
https://www.pharmacompass.com/pdf/news/teva-pharmas-pralatrexate-tentatively-approved-in-us-an-anti-cancer-therapy-1453550605.pdf
http://www.fiercepharmaasia.com/press-releases/spectrum-pharmaceuticals-divests-rights-zevalin-ibritumomab-tiuxetan-japan
Market Place
Share 
